drugset / Trial / NCT00435448
Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
RandomizedFactorialDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of lonidamine (50mg, 150mg) compared to placebo in subjects with symptomatic BPH.
Timeline
- Start
- 2005-06
- Primary completion
- 2006-12
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lonidamine | Small molecule | 50 mg | — |
| Subject | Lonidamine | Small molecule | 150 mg | — |